Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Acumen Pharmaceuticals | 140.98 Mn | 140.98 Mn | - | 33.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.36% |
| Dec 31, 2025 | -103.40% |
| Sep 30, 2025 | 20.98% |
| Jun 30, 2025 | -64.36% |
| Mar 31, 2025 | -67.03% |
| Dec 31, 2024 | 724.13% |
| Jun 30, 2024 | 92.79% |
| Mar 31, 2024 | 94.59% |
| Dec 31, 2023 | -187.52% |
| Jun 30, 2023 | -40,356.01% |
| Mar 31, 2023 | -35.54% |
| Dec 31, 2022 | -65.84% |
| Sep 30, 2022 | 99.83% |
| Jun 30, 2022 | -1,149.56% |
| Dec 31, 2021 | 221,640.71% |